[Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors].
de Abajo
Francisco J
FJ
División de Farmacoepidemiología y Farmacovigilancia, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, España.
Montero
Dolores
D
Calvo
Gonzalo
G
D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems; D002648:Child; D017277:Drug Approval; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013030:Spain
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors